01 1Dasami Lab
01 1DROXIDOPA (PROCESS-II)
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-01-10
Pay. Date : 2020-11-25
DMF Number : 35368
Submission : 2020-11-27
Status : Active
Type : II
20
Dasami Lab Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DROXIDOPA (PROCESS-II), with a corresponding US DMF Number 35368.
Remarkably, this DMF maintains an Active status since its submission on November 27, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 10, 2021, and payment made on November 25, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
